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ABSTRACT A bacterial expression system was used to
produce simian virus 40 large tumor antigen (T antigen) in the
absence of the extensive psranslational modifications that
occur in mammalian cells. Wild-type T antigen produced in
bacteria retained a specific subset of the biochemical activities
displayed by its mammalian counterpart. Eschenchia coli T
antigen functioned as a helicase and bound to DNA faments
containing either site I or the wild-type origin of replication in
a manner identical to mammalian T antigen. However, T
antigen purified from E. colt did not efficiently bind to site H,
an essential cis element within the simian virus 40 origin of
replication. It therefore could not unwind origin-containing
plasmids or efficiently replicate simian virus 40 DNA in vito.
The ability ofprotein phosphorylation to modulate the intrinsic
preference of full-length T antigen for either site I or site II is
dicssed.
Protein phosphorylation has been demonstrated to be an
effective means of regulating both the catalytic activity of
numerous enzymes and the assembly of macromolecular
structures (1-7). Subtle alterations in the sites that are
phosphorylated may result in conformational changes that
could, in turn, affect protein function. It is conceivable that,
in some instances, basal levels of phosphorylation may be
required for proper folding of a polypeptide and full activity,
whereas subsequent levels of modification may have a more
pronounced regulatory effect. The wealth of genetic and
biochemical information concerning the large tumor antigen
(T antigen) encoded by simian virus 40 (SV40) (for review,
see ref. 8) makes this phosphoprotein an excellent model with
which to examine the consequences of multiple phosphoryl-
ation events.
T antigen is phosphorylated at two clusters of serine and
threonine residues (9-11). Biochemical studies have indi-
cated that 80%o ofthe phosphate moieties on the molecule can
be removed by treatment with calf intestinal alkaline phos-
phatase (CLAP), while the remaining 20%6 are refractory to
enzymatic dephosphorylation (12-15). Furthermore, analysis
of CIAP-treated protein revealed an increase in its ability to
direct origin-specific DNA synthesis in vitro (13, 14). Al-
though the ATPase activity of the CIAP-treated protein was
not altered (13-15), its ability to bind specific DNA se-
quences in the SV40 origin of replication increased several-
fold (13, 15, 16). The SV40 origin of replication contains two
T antigen binding sites (17, 18). While each of these sites
contains multiple copies of the 5' GAGGC 3' sequence
recognized by T antigen, the arrangement of the pentanucle-
otide motifs differs markedly, and T antigen binding to either
site has different biological consequences (18-20). Site I
contains a high-affinity T antigen binding site, participates in
the autoregulation of early transcription, and is an auxiliary
component of the origin of replication (19-21). Site II also
functions in transcriptional control but is primarily an essen-
tial cis element within the minimal SV40 origin of replication
(20, 22). CLAP-treated T antigen displays a 4-fold increase in
binding to site II and a 2-fold increase in binding to site 1 (13,
15).
Phospho amino acid analysis performed in several labora-
tories has confirmed that the phosphates present on serine
residues are removed by CIAP treatment, while those cova-
lently attached to the two threonine residues (124 and 701) are
unaffected (12, 14, 15). Furthermore, genetic studies have
indicated that, while Thr-701 is dispensible for T antigen
function and virus viability (23, 24), Thr-124 is absolutely
essential (24, 25). To examine the activity of T antigen that
lacks the posttranslational modifications provided by a mam-
malian cell, the protein was expressed in bacteria, and
several biologically relevant biochemical parameters were
evaluated in vitro.
MATERIALS AND METHODS
Expression of T Antigen in Escherichia coi. The coding
sequences for SV40 T antigen were cloned into a T7 expres-
sion plasmid, pRK170 (obtained from R. Kostriken, Cold
Spring Harbor Laboratory). pRK170 was derived from
pAR3038 (26) by deletion of the sequences between EcoRI
and EcoRV downstream of the 17 transcription termination
signal. The Nde I restriction site of the vector contains the
ATG start codon for translation of the cloned sequence. The
sequence surrounding the ATG ofT antigen was converted to
an Nde I site by site-directed mutagenesis (27) using a cDNA
copy of the SV40 HindIII fragment (nucleotides 4002-5171)
in pUC119. Appropriate clones were identified first by pos-
itive hybridization to a 32P-labeled oligonucleotide and sub-
sequently by their sensitivity to Nde I. The Nde I-HindIII
fragment from this plasmid was ligated together with the
remainder of T antigen cDNA coding sequences (purified
HindIII-BamHI fragment, nucleotides 2533-4002) into Nde
I-BamHI-digested pRK170. The resulting pT7Tag plasmid
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was used to transform BL21(DE3) bacteria (26) to ampicillin
resistance. Isolated colonies demonstrated less than 1%
viability when plated on agar containing isopropyl f3
D-thiogalactoside and ampicillin. To create an expression
plasmid that conferred resistance to kanamycin upon the host
bacteria, the Bgl II-EcoRI fragment from pAR3038 was
cloned into BamHI-EcoRI-digested pMK16#1 (22). The
resulting plasmid was digested 'with BamHI and Xba I and
ligated to the Xba I-BamHI fragment from pT7Tag. This final
construct was termed pABT7T.
Proteins. T antigen from a mammalian source was pro-
duced in HeLa cell'suspension cultures (5 x 105 cells per ml)
infected with a mixture ofwild-type adenovirus 5 (as a helper)
and a defective adenovirus carrying the coding sequence of
SV40 T antigen in early region 1 at multiplicities of infection
of 10 and 100, respectively. Cells were harvested 42-44 hr
postinfection, and extracts were prepared as described (28).
Full-length T antigen from E. coli was prepared in the
following manner. Cultures of BL21(DE3)Lyss (ref. 19) car-
rying the pABT7T plasmid were grown at 370C in LB medium
containing kanamycin and chloramphenicol. When the OD6w
reached 0.5, isopropyl -D-thiogalactoside was added to a
final concentration of 0.4 mM and the flasks were kept in a
shaking incubator at 370C for an additional 2 hr. Bacteria
were harvested by centrifugation and'suspended in a small
volume of buffer C [50mM TrisHCl, pH 7.4/500 mM LiCl/1
mM EDTA/10% (vol/vol) glycerol]. Phenylmethylsulfonyl
fluoride was added to a final concentration of 1 mM, and the
suspension was lysed under 1500 psi (1 psi = 6.89 kPa) of
nitrogen in a french press. After centrifugation at 76,800 x g
(ravg), the clarified extract was loaded onto a 3.5-cm x
47.5-cm Sephadex G-100 column equilibrated in buffer C, and
the column was eluted at a flow rate of 12 ml/hr. This step
allowed some separation of the full-length protein from
shorter contaminants. Fractions containing full-length T an-
tigen were pooled and loaded sequentially onto a protein
A-Sepharose column followed by a protein A-Sepharose
column onto which the monoclonal antibody Pab419 (29) had
been coupled (28). The column was then washed and eluted
as described (28).
DNA Replication Reactions. Cytoplasmic extracts were
prepared from human 293 cells grown in suspension (30).
After adjusting the final concentration of NaCl in the super-
natant to 0.1 M, the extract was clarified by centrifugation at
100,000 x g, and the resulting supernatant fraction (S100)
was divided into aliquots and stored at -70TC. This fraction
was used for all DNA replication reactions. DNA replication
in vitro was measured by the incorporation of [a-32P]dATP
into trichloroacetic acid-insoluble material (30).
Helicase Assay. mpSV2 contains the HindIII-Hpa II SV40
fragment (nucleotides 5171-346) cloned into Sma I/HindIII-
digested M13mp9. A synthetic 42-base oligonucleotide (5'
GTTTTCCCAGTCACGACGTTGTAAAACGACGGC-
CAGTGAATT 3') was synthesized on an Applied Biosys-
tems 380-A DNA synthesizer and purified by electrophoresis
on a denaturing polyacrylamide gel. Following adsorption
onto a reverse-phase C18 SepPak cartridge (Waters), the
oligonucleotide was eluted with 60% methanol, lyophillized
to dryness, and resuspended in H20. Fifty nanograms of
purified oligonucleotide was annealed to 1.5 pg of mpSV2 in
10 mM Tris-HCl, pH 8.5/1 mM MgCl2 at 50°C for 1 hr.
Following slow cooling to room temperature, the annealed
template was labeled with the Klenow fragment of DNA
polymerase I (in the presence of [a-32P]dCTP and nonradio-
active dGTP) and subsequently extracted by both phenol and
chloroform. The labeled DNA was ethanol precipitated,
resuspended, and loaded onto a 0.6-cm x 26-cm Sepharose
CL-4B column. The column was equilibrated and developed
in 10 mM Tris-HCl, pH 7.4/1 mM EDTA/100 mM NaCl, and
peak fractions containing labeled DNA were collected and
used directly. Helicase reaction mixtures contained -10 ng of
labeled substrate in 30 mM Hepes-KOH, pH 8.0/4 mM
ATP/7 mM MgCl2/0.5 mM dithiothreitol and were incubated
for 1 hr at 370C. Reactions were terminated by adding SDS,
EDTA, and glycerol to 0.6%, 30 mM, and 5%, respectively.
Products were analyzed on 8% native polyacrylamide gels
containingagradientof0.5x to 2.5x TBE (lx TBE = 90mM
Tris/64.6 mM boric acid/2.5 mM EDTA, pH 8.3). Gels were
dried onto DE 81 paper (Whatman) and exposed to Kodak
XAR film at room temperature.
DNA-Binding Reactions. Plasmid DNA templates contain-
ing site I (pOS-i; SV40 nucleotides 5171-5228), site II
(pSVOdl3; SV40 nucleotides 5209-128), and the wild-type
origin (pSVO+; SV40 nucleotides 5171-128) have been de-
scribed (31, 32). An equimolar mixture of these plasmids was
assembled and digested to completion with Taq I. This
enzyme releases intact SV40 origin sequences and generates
several plasmid-derived fragments. The mixture was labeled
with the Klenow fragment of DNA polymerase I, extracted
with phenol and chloroform, and precipitated with ethanol.
Fifty nanograms of this mixture was incubated with various
amounts of each T antigen in origin-binding buffer (10 mM
Hepes, pH 7.4/100 mM KCl/1 mM MgCl2/5% glycerol/
bovine serum albumin at 50 pg/ml) for 1 hr at 0°C. Five
micrograms of purified Pab419 (29) was added, and the
incubation was continued for an additional 20 min. One
hundred microliters of a 10% (vol/vol) protein A-Sepharose
slurry in NET buffer (50 mM Tris-HCl, pH 7.4/150 mM
NaCl/5 mM EDTA/0.05% Nonidet P-40) containing soni-
cated calf thymus DNA at 20 ,ug/ml was then added, and the
reaction mixtures were incubated on a rocker for 50 min at
40C. The beads were pelleted, washed three times with 1 ml
of NET buffer, resuspended in 1% SDS/25 mM EDTA,
incubated at 65°C for 15 min, and electrophoresed on a 6%
native polyacrylamide gel in a TBE buffer system. Gels were
dried onto DE 81 paper (Whatman) and exposed to Kodak
XAR film at room temperature.
Origin-Specific Unwinding Assay. Various amounts of pu-
rified SV40 T antigen were added to reaction mixtures (50 ul)
containing 40 mM Hepes-KOH (pH 7.5), 8 mM MgCl2, 0.5
mM dithiothreitol,4mM ATP (from a 100 mM, pH 7.0 stock),
40 mM creatine phosphate, creatine phosphokinase at 1
,g/ml, 1 ,g of bovine serum albumin, 100 ng of calf thymus
topoisomerase I, 1.2 pg ofRFA (a eukaryotic single-stranded
DNA-binding protein) (33, 34), 20 ,ug of fraction SSI (33), and
100 ng of template DNA (pSV011; ref. 35). Reaction mixtures
were incubated at 370C for 15 min and terminated by the
addition of SDS and EDTA to 0.4% and 100 mM, respec-
tively. Protease XIII (50 ug/ml) and RNase A (10 ,ug/ml)
were then added, and the samples were incubated for an
additional 30 min at 370C. The digested samples were then
extracted once with an equal volume of phenol/chloroform,
1:1, and the DNA was precipitated with ethanol. The degree
of unwinding was determined by electrophoresis through
1.3% agarose gels in TBE and visualized by staining with
ethidium bromide and exposing the gel to x-ray film.
RESULTS
Expression of T Antigen in E. coil. The cDNA encoding
full-length SV40T antigen was cloned in front ofthe promoter
for T7 gene 10 (see Materials and Methods). This expression
plasmid was transformed into a strain of E. coli harboring a
A prophage containing the gene for T7 RNA polymerase
under the control of the lac UV5 promoter. Induction of
cultures with isopropyl ,B-D-thiogalactoside results in the
synthesis of large amounts of T7 RNA polymerase which, in
turn, directs transcription from the T7 gene 10 promoter (26).
T antigen was purified from induced cultures by modifica-
tions of existing immunoaffinity procedures (28). The yield of
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T antigen purified by this method was approximately 50 ug of
full-length protein from 2 liters of induced cultures. In
addition to poor levels of expression, various amounts of
immunologically related, truncated proteins copurified with
the full-length polypeptide. The actual amounts of these
proteins varied among preparations. The full-length polypep-
tide was the major protein species present in preparations
used to perform the experiments that follow. Side-by-side
analysis of proteins purified from bacterial and mammalian
sources on SDS/PAGE reveals that E. coli T antigen mi-
grates slightly slower than its mammalian counterpart (Fig.
1). Electrophoresis of both proteins in a single lane results in
a doublet of bands corresponding to the individual compo-
nents (data not shown). Although we do not precisely know
the nature of this difference, one possibility is that the
mobility difference may be attributed to differences in the
phosphorylation of the proteins produced in E. coli vs. HeLa
cells. 32p labeling of induced cultures revealed that E. coli T
antigen is phosphorylated several orders of magnitude less
than the protein from HeLa cells (data not shown). Differ-
ences in both the phosphate pools and the efficiency of
labeling these two very different cell types prohibit a more
quantitative analysis. The overall amount of phospho amino
acids in prokaryotes is known to be much lower than in
eukaryotic organisms. Experiments performed with 32p_
labeled proteins from E. coli demonstrated that -96% of the
acid-stable phospho amino acids are phosphoserine residues
(see ref. 36 for review). It is worth noting, however, that
phosphorylation can alter the migration pattern of proteins in
one-dimensional SDS/polyacrylamide gels (for example, see
ref. 37). This also holds true for T antigen, as mutation of the
Thr-701 phosphorylation site to Ala (24) alters the protein's
mobility on SDS/polyacrylamide gels (Fig. 1).
Biochemical Properties of E. coli T Antigen. The ability of
E. coli T antigen or HeLa T antigen to direct the synthesis of
SV40DNA was evaluated by using an in vitro system (30, 38).
Side-by-side analysis of equal microgram amounts of E. coli
T antigen or HeLa T antigen (confirmed by SDS/PAGE)
revealed that reactions programmed with E. coli T antigen
replicated DNA to levels 10-15% of those directed by reac-
tions programmed with its mammalian counterpart (Fig. 2).
Furthermore, this reduced level of synthesis was origin
specific, as it was completely abolished by the deletion of
four base pairs within site II (22).
The specific DNA-binding property of these proteins was
compared by incubating the purified proteins with a mixture
of end-labeled DNA composed of three origin fragments
present in equimolar amounts as well as several nonspecific
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FIG. 1. Anamolous mobility of
E. coli T antigen on SDS/poly-
acrylamide gels. Various amounts
of immunoaffinity purified T anti-
gen from HeLa cells or from E.
coli were subjected to electropho-
-_ resis on a SDS/12.5% polyacryl-
amide gel. The gel was fixed and
stained with silver. Molecular size
markers (MW): 200 kDa, myosin;
116 kDa, P-galactosidase; 97 kDa,
phosphorylase b; 66 kDa, bovine
serum albumin; 43 kDa, ovalbu-
min; 30 kDa, carbonic anhydrase.
The lane marked HeLa Ala-701
contains a mutant T antigen with a
substitution of alanine for threo-
nine at residue 701 (24).
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FIG. 2. Full-length T antigen from E. coli directs levels of in vitro
DNA synthesis that are 10-15% of those directed by T antigen
purified from a mammalian source. Various amounts of purified T
antigen produced either in HeLa cells or in E. coli were used to
program in vitro DNA synthesis reactions containing either wild-type
origin (ori+) or mutant origin (ori-) templates. The amount ofDNA
synthesis is expressed as the number of picomoles of dAMP incor-
porated into acid-insoluble material.
DNA fragments. Protein-DNA complexes, once formed, are
immunoprecipitated (39), and the DNA fragments bound are
visualized on autoradiograms of polyacrylamide gels. Fig. 3
demonstrates that E. coli T antigen fails to form complexes
with the site II fragment at concentrations where HeLa T
antigen binds efficiently. E. coli T antigen also demonstrates
greater binding to nonspecific DNA fragments than to the site
II fragment. However, E. coli T antigen binds to fragments
containing site I only or the wild-type origin with the same
efficiency as HeLa T antigen. Binding of T antigen to the
wild-type origin fragment primarily reflects binding to the
high-affinity site I. DNase I footprinting of E. coli T antigen
or HeLa T antigen bound to wild-type origin fragments has
confirmed that both proteins completely protect site I, while
only HeLa T antigen efficiently protects site II (data not
shown).
T antigen from E. coli possesses an intrinsic ATPase
activity, and this activity is inhibited by monoclonal antibod-
ies (40) that inhibit ATP hydrolysis by HeLa T antigen (data
not shown). The ATPase activity of the protein (41, 42) is
required for it to function as a DNA helicase (43). This
activity can be measured by monitoring the ability of the
protein to displace a labeled 51-base oligonucleotide from a
heteroduplex helicase substrate in the presence of ATP and
Mg2+. Fig. 4 demonstrates that E. coli T antigen and HeLa
T antigen function identically in this assay. A second assay,
which requires the helicase function of T antigen, measures
the unwinding of a closed, circular DNA template containing
the SV40 origin (44, 45) in the presence of several cellular
proteins, including a eukaryotic single-stranded DNA-
binding protein (RFA; refs. 33 and 34) and toposomerase I.
Unwinding of the template is reflected by the appearance of
faster migrating supercoiled forms of the labeled DNA evi-
dent in reactions containing HeLa T antigen (Fig. 5). The
ability of E. coli T antigen to function in this assay parallels
its ability to replicate SV40 DNA and its apparent inability to
Biochemistry: Mohr et al.
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FIG. 3. Specific DNA-binding activity ofE. coli T antigen versus
HeLa T antigen. (Upper) Various amounts of immunoaffinity T
antigen from E. coli or HeLa cells (lanes: 1, 50 ng; 2, 150 ng; 3, 450
ng; 4, 1000 ng) were incubated with a mixture of end-labeled DNA
containing three origin fragments in equimolar amounts (lane M).
After 1 hr at 0C, T antigen was immunoprecipitated from the
reaction mixture, and the DNA fragments bound were separated on
native 6% polyacrylamide gels and visualized by autoradiography.
(Lower) Schematic of the SV40 origin fragments used in the DNA-
binding assay. wt, site I + site II; I, site I only; II, site II only.
form complexes with site II DNA fragments. This provides
evidence that efficient site II binding, in addition to DNA
helicase activity, is necessary for proper unwinding activity.
DISCUSSION
The biochemical activities of T antigen purified from pro-
karyotic or eukaryotic sources have been evaluated. In
approximately half of these assays, the activity of E. coli T
antigen was indistinguishable from that of HeLa T antigen.
The reduced activity displayed by E. coli T antigen in the
remaining assays can be explained in terms of its reduced
FIG. 4. E. coli T antigen pos-
sesses wild-type levels of helicase
activity. Purified T antigen from
E. coli or HeLa cells was incu-
bated with the labeled helicase
substrate in the presence of ATP
for 1 hr at 370C. The products of
the reaction were separated on
native 8% polyacrylamide/TBE
buffer gradient gels and visualized
by autoradiography.
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FIG. 5. The origin-specific un-
winding activity of E. coli T anti-
gen is dramatically reduced rela-
tive to HeLa T antigen. Purified T
antigen from E. coli or HeLa cells
was incubated with the purified,
labeled DNA products of an in
vitro DNA synthesis reaction in
the presence of replication protein
A, calf thymus topoisomerase I,
fraction SSI, and ATP for 15 min
at 370C. The reaction products
were analyzed on 1% agarose gels
and visualized by autoradiog-
raphy.
ability to bind site II. Although T antigen from E. coli binds
to DNA fragments containing the wild-type origin and site I
with the same efficiency as HeLa T antigen, it fails to
complex with fragments containing only site II at concentra-
tions where HeLa T antigen binds efficiently. The impaired
ability ofE. coliT antigen to complex with site II, an essential
cis element within the SV40 origin of replication, directly
affects its performance in replication and unwinding assays.
E. coli T antigen directs origin-specific DNA synthesis at
levels that are 10-15% of those directed by T antigen purified
from HeLa cells infected with an adenovirus expression
vector and functions at reduced levels in an origin-specific
unwinding assay. Both E. coli T antigen and HeLa T antigen,
however, exhibit similar levels of DNA helicase activity.
A single domain encompassing residues 132-246 of T
antigen contains all of the information necessary for the
specific recognition of site I and site II (refs. 31, 46, and 47;
D.M., M.S., and Y.G., unpublished observations). Although
both sites contain multiple copies of the 5' GAGGC 3'
sequence recognized by T antigen, the arrangement of the
pentanucleotides is fundamentally different (18). Production
of a truncated protein in E. coli composed of amino acids
132-246 has revealed that this isolated domain binds effi-
ciently to both site I and site 11 (48). The ability of this region
to function, in general, as a DNA-binding entity appears
unaffected. Full-length E. coliT antigen, however, only binds
efficiently to site I and wild-type origin fragments but fails to
complex with site II. Packaging the DNA-binding domain
within the superstructure of the protein has imposed con-
straints on the ability of the domain to recognize site II. The
ability to modulate the conformation of the superstructure
could have profound consequences on the behavior of the
DNA-binding domain and would thus represent an excellent
target for regulation by phosphorylation. Although we cannot
completely rule out the possibility that a small cluster of
amino acids within this domain responsible for efficient site
II recognition cannot fold correctly in the intact protein, we
believe this view is unlikely and favor instead an explanation
centering on the phosphorylation of E. coli T antigen.
Phosphorylation of T antigen regulates its specific DNA-
binding activity (13, 15, 16, 49), its ability to direct origin-
specific DNA synthesis (13, 14), but does not affect the
protein's intrinsic DNA helicase activity (15). Furthermore,
this modification indirectly affects DNA-binding activity as
both phosphorylation clusters lie outside of the origin-
specific DNA-binding domain. The phenotype of E. coli T
antigen could then be explained by the absence of a crucial
phosphorylation event, which would activate the protein,
allow efficient binding to site II, and thus permit efficient
origin-specific DNA synthesis. The low level of DNA syn-
thesis observed may reflect phosphorylation ofT antigen by
kinases in the S100, as CIAP-treated T antigen becomes
6482 Biochemistry: Mohr et al.
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rephosphorylated under these conditions (14). Subsequent
phosphorylation on serine residues would function to down-
regulate the replication and DNA-binding activities of the
protein. Consistent with this hypothesis, CIAP treatment of
HeLa T antigen, which activates DNA replication and site II
binding activity, cannot fully dephosphorylate the protein
(12-15). Following CIAP treatment, phosphate is found pre-
dominately on Thr-124 and Thr-701 (14, 15). Although Thr-
701 is dispensable for SV40 DNA replication, Thr-124 is
absolutely essential (24). The final correlation is indeed
striking, as full-length T antigen produced in E. coli is a partial
phenocopy of a mutant at Thr-124. Mutants at this residue are
totally defective for replicating SV40 DNA in vivo and fail to
bind to DNA fragments containing only site II (24).
SV40 has successfully usurped the host cells' posttransla-
tional modification machinery to further its own purposes. T
antigen is a multifunctional protein and must be distributed to
many different functions in a productive lytic infection.
Phosphorylation is thus a mechanism in which extensive
heterogeneity can be generated in an otherwise homogenous
population of molecules. For example, molecules lacking
phosphates on Thr-124 may be involved in autoregulation of
T antigen synthesis (50-53), which requires binding to site I,
while a hyperphosphorylated class may activate late tran-
scription (54-57). Phosphorylation of Thr-124, however, may
be obligatory on molecules participating in SV40 DNA rep-
lication. The creation and marking of T antigen subpopula-
tions ensures that all molecules of T antigen will not be
directed to replicate SV40 DNA and can thus be deployed to
perform other functions crucial to the viral life cycle.
Protein phosphorylation can also account for heterogene-
ity among cellular proteins. Reversible covalent modification
provides a means to modulate a variety of processes in a
temporal fashion (for example, see ref. 58). Families of
immunologically related proteins have been shown to be
involved in regulation of cellular gene expression (59); fur-
thermore, several of these families can function as nuclear
oncoproteins (for review, see ref. 60). Multiple members of
a given family are, in some instances, generated by differ-
ential splicing events (61) or are encoded by distinct genetic
units (for example, see refs. 48 and 62). In several instances,
however, extensive posttranslational modification accounts
for the heterogeneity among members of a protein family (59,
63-66). Further study of these proteins will reveal any
functional significance attached to this heterogeneity and will
almost certainly unravel additional unexpected levels of
complexity.
Note Added in Proof. The cdc2 protein kinase (purified from mam-
malian cells) phosphorylates T antigen on Thr-124. Phosphorylation
of E. coli T antigen by the cdc2 protein kinase restores its ability to
bind site II and to subsequently initiate SV40DNA synthesis in vitro
(D.M., L. Brizuela, I.J.M., D. Marshak, Y.G., and D. Beach,
unpublished results).
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